Published in Mol Psychiatry on July 01, 1996
Neuropeptide-mediated excitability: a key triggering mechanism for seizure generation in the developing brain. Trends Neurosci (1998) 1.96
The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist. Brain Res (1997) 1.28
Infantile spasms: hypothesis-driven therapy and pilot human infant experiments using corticotropin-releasing hormone receptor antagonists. Dev Neurosci (1999) 0.81
Corticotropin releasing hormone antagonist does not prevent adrenalectomy-induced apoptosis in the dentate gyrus of the rat hippocampus. Stress (1998) 0.78
Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science (1981) 9.64
Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci U S A (1995) 2.70
Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci U S A (1994) 2.14
Corticotropin-releasing hormone-induced seizures in infant rats originate in the amygdala. Ann Neurol (1992) 1.95
Corticotropin-releasing hormone is a rapid and potent convulsant in the infant rat. Brain Res Dev Brain Res (1991) 1.90
Synthetic competitive antagonists of corticotropin-releasing factor: effect on ACTH secretion in the rat. Science (1984) 1.87
Chemical and biological characterization of corticotropin releasing factor. Recent Prog Horm Res (1983) 1.86
Corticotropin releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons. Science (1983) 1.77
The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF. Proc Natl Acad Sci U S A (1992) 1.60
Corticotropin releasing factor produces increases in brain excitability and convulsive seizures in rats. Brain Res (1983) 1.55
Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of corticotropin-releasing factor. Brain Res (1991) 1.46
Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor. Proc Natl Acad Sci U S A (1995) 1.45
Developmental profile of messenger RNA for the corticotropin-releasing hormone receptor in the rat limbic system. Brain Res Dev Brain Res (1996) 1.44
Diurnal variations in the content of preprocorticotropin-releasing hormone messenger ribonucleic acids in the hypothalamic paraventricular nucleus of rats of both sexes as measured by in situ hybridization. Endocrinology (1989) 1.29
The ontogeny of brain receptors for corticotropin-releasing factor and the development of their functional association with adenylate cyclase. J Neurosci (1988) 1.27
Peptide-induced infant status epilepticus causes neuronal death and synaptic reorganization. Neuroreport (1995) 1.24
Corticotropin-releasing factor suppresses the afterhyperpolarization in cerebellar Purkinje neurons. Neurosci Lett (1993) 1.15
ACTH does not control neonatal seizures induced by administration of exogenous corticotropin-releasing hormone. Epilepsia (1995) 1.06
Postnatal development of regional binding of corticotropin-releasing factor and adenylate cyclase activity in the rat brain. Prog Neuropsychopharmacol Biol Psychiatry (1992) 0.99
Localization of corticotropin-releasing hormone (CRH) receptor mRNA in adult rat brain by in situ hybridization histochemistry. Endocrinology (1994) 0.97
Synthesis and relative potencies of new constrained CRF antagonists. J Med Chem (1993) 0.96
Differential antagonist activity of alpha-helical corticotropin-releasing factor9-41 in three bioassay systems. Endocrinology (1991) 0.92
Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science (1981) 9.64
Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science (1973) 7.47
Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature (1983) 5.20
Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology (1983) 4.67
Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci U S A (2001) 3.23
Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan. J Neurooncol (2008) 2.97
Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci U S A (2001) 2.87
Coupling of hormonal stimulation and transcription via the cyclic AMP-responsive factor CREB is rate limited by nuclear entry of protein kinase A. Mol Cell Biol (1993) 2.79
Diversity of Conus neuropeptides. Science (1990) 2.78
Peptide neurotoxins from fish-hunting cone snails. Science (1985) 2.77
Pneumococcal polysaccharide immunization in infants and children. Pediatrics (1978) 2.67
Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature (1982) 2.44
Characterization of a bipartite activator domain in transcription factor CREB. Cell (1990) 2.41
Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature (1986) 2.29
Psychiatric sequelae of posttraumatic stress disorder in women. Arch Gen Psychiatry (1997) 2.29
Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity. J Biol Chem (2000) 2.20
Rapid regression of uterine leiomyomas in response to daily administration of gonadotropin-releasing hormone antagonist. Fertil Steril (1993) 2.09
CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat. Psychopharmacology (Berl) (1991) 2.04
Corticotropin-releasing hormone-induced seizures in infant rats originate in the amygdala. Ann Neurol (1992) 1.95
Effects of propranolol in non-Q-wave acute myocardial infarction in the beta blocker heart attack trial. Am J Cardiol (1990) 1.94
Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science (1996) 1.91
Corticotropin-releasing hormone is a rapid and potent convulsant in the infant rat. Brain Res Dev Brain Res (1991) 1.90
Synthetic competitive antagonists of corticotropin-releasing factor: effect on ACTH secretion in the rat. Science (1984) 1.87
Chemical and biological characterization of corticotropin releasing factor. Recent Prog Horm Res (1983) 1.86
Corticotropin releasing factor produces behavioural activation in rats. Nature (1982) 1.82
Primary structure of corticotropin-releasing factor from ovine hypothalamus. Proc Natl Acad Sci U S A (1981) 1.78
Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study. J Neurosci (1985) 1.77
Corticotropin releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons. Science (1983) 1.77
Sex differences in depression: a role for preexisting anxiety. Psychiatry Res (1995) 1.76
Pilot trial of IOM duty hour recommendations in neurology residency programs: unintended consequences. Neurology (2011) 1.69
Somatostatin. Recent Prog Horm Res (1975) 1.67
Adaptive modulations of martensites. Phys Rev Lett (2010) 1.62
Febrile seizures: an appropriate-aged model suitable for long-term studies. Brain Res Dev Brain Res (1997) 1.60
Corticotropin-releasing factor: actions on the sympathetic nervous system and metabolism. Endocrinology (1982) 1.58
Characterization of rat hypothalamic corticotropin-releasing factor. Proc Natl Acad Sci U S A (1983) 1.58
Education research: Bias and poor interrater reliability in evaluating the neurology clinical skills examination. Neurology (2009) 1.58
"Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis. J Clin Endocrinol Metab (1982) 1.57
Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. Life Sci (1982) 1.57
Primary structure of the ovine hypothalamic luteinizing hormone-releasing factor (LRF) (LH-hypothalamus-LRF-gas chromatography-mass spectrometry-decapeptide-Edman degradation). Proc Natl Acad Sci U S A (1972) 1.57
Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive. N Engl J Med (1981) 1.57
Corticotropin releasing factor produces increases in brain excitability and convulsive seizures in rats. Brain Res (1983) 1.55
Assay of corticotropin releasing factor. Methods Enzymol (1983) 1.53
Fracture mechanisms in bulk metallic glassy materials. Phys Rev Lett (2003) 1.52
Development of an integrated laboratory information management system for the maize mapping project. Bioinformatics (2003) 1.50
Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): a strategy for vascular immunotargeting of drugs. Proc Natl Acad Sci U S A (1999) 1.46
Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats. Psychopharmacology (Berl) (1999) 1.46
Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor. Proc Natl Acad Sci U S A (1995) 1.45
Experimental aspects of peripheral vascular occlusion of the intestine. Surg Gynecol Obstet (1965) 1.45
Corticotropin-releasing hormone (CRH)-containing neurons in the immature rat hippocampal formation: light and electron microscopic features and colocalization with glutamate decarboxylase and parvalbumin. Hippocampus (1998) 1.42
The effect of somatostatin analogs on secretion of growth, pancreatic, and gastrointestinal hormones in man. J Clin Endocrinol Metab (1981) 1.42
CRF2 receptor activation prevents colorectal distension induced visceral pain and spinal ERK1/2 phosphorylation in rats. Gut (2005) 1.41
Detection and purification of inhibin using antisera generated against synthetic peptide fragments. Methods Enzymol (1989) 1.38
Reversed-phase high-performance liquid chromatography: preparative purification of synthetic peptides. J Chromatogr (1984) 1.37
Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. N Engl J Med (1984) 1.35
Role of CRF in stress-related alterations of gastric and colonic motor function. Ann N Y Acad Sci (1993) 1.33
Transmembrane topography of nicotinic acetylcholine receptor: immunochemical tests contradict theoretical predictions based on hydrophobicity profiles. Biochemistry (1986) 1.33
In vivo corticotropin-releasing factor-induced secretion of adrenocorticotropin, beta-endorphin, and corticosterone. Endocrinology (1982) 1.32
Abnormal corticosterone regulation in an immature rat model of continuous chronic stress. Pediatr Neurol (1996) 1.30
Conotoxins. J Biol Chem (1991) 1.28
The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist. Brain Res (1997) 1.28
Corticotropin releasing factor (CRF): immunoreactive neurones and fibers in rat hypothalamus. Regul Pept (1982) 1.27
Purification and partial characterization of inhibin from porcine follicular fluid. Biochem Biophys Res Commun (1985) 1.27
Characterization of a teleost gonadotropin-releasing hormone. Proc Natl Acad Sci U S A (1983) 1.26
Are smokers with alcohol disorders less likely to quit? Am J Public Health (1996) 1.25
A new family of Conus peptides targeted to the nicotinic acetylcholine receptor. J Biol Chem (1995) 1.24
D-Trp8-somatostatin: an analog of somatostatin more potent than the native molecule. Biochem Biophys Res Commun (1975) 1.24
Characterization of rat hypothalamic growth hormone-releasing factor. Nature (1983) 1.24
Human pancreatic growth-hormone-releasing factor selectively stimulates growth-hormone secretion in man. Lancet (1983) 1.23
Biologic and immunologic activities and applications of somatostatin analogs. Metabolism (1978) 1.23
Conantokin-T. A gamma-carboxyglutamate containing peptide with N-methyl-d-aspartate antagonist activity. J Biol Chem (1990) 1.22
Vasoactive intestinal peptide receptor antagonist [4Cl-D-Phe6, Leu17] VIP. Am J Physiol (1986) 1.22
Expression-cloning and sequence of a cDNA encoding human growth hormone-releasing factor. Nature (1983) 1.20
Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF- and stress-related alterations of gastric and colonic motor function. J Pharmacol Exp Ther (1997) 1.19
Corticotropin-releasing factor (CRF): central effects on mean arterial pressure and heart rate in rats. Endocrinology (1982) 1.19
A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue. Am J Obstet Gynecol (1983) 1.19
Strain-induced insulator state and giant gauge factor of La0.7Sr0.3CoO3 films. Phys Rev Lett (2008) 1.18
Location of antigenic determinants on primary sequences of subunits of nicotinic acetylcholine receptor by peptide mapping. Biochemistry (1986) 1.18
Perioperative allogeneic blood transfusions. Survival in patients with resected carcinomas of the colon and rectum. Arch Surg (1985) 1.17
Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty. J Clin Endocrinol Metab (1981) 1.17
Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report. N Engl J Med (1981) 1.16
Protein disulfide isomerase is essential for viability in Saccharomyces cerevisiae. Gene (1991) 1.16
Bombesin:potent effects on thermoregulation in the rat. Science (1977) 1.16
Inhibin A-subunit cDNAs from porcine ovary and human placenta. Proc Natl Acad Sci U S A (1986) 1.16
Contraction of major artery segments of rat by fish neuropeptide urotensin II. Am J Physiol (1987) 1.15
Importance of FSH-releasing protein and inhibin in erythrodifferentiation. Nature (1988) 1.15
B cells are not essential for peripheral T-cell tolerance. Proc Natl Acad Sci U S A (1996) 1.15
Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol. J Clin Invest (1983) 1.14
Characterization of melanin-concentrating hormone from rat hypothalamus. Endocrinology (1989) 1.13
[Preliminary observations on the mechanism of action of somatostatin, a hypothalamic factor inhibiting the secretion of growth hormone]. C R Acad Sci Hebd Seances Acad Sci D (1972) 1.13
Inactivation of a serotonin-gated ion channel by a polypeptide toxin from marine snails. Science (1998) 1.12
Ligand requirements of the human corticotropin-releasing factor-binding protein. Endocrinology (1995) 1.11
Stress-induced inhibition of reproductive functions: role of endogenous corticotropin-releasing factor. Science (1986) 1.11
Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta. Nature (1987) 1.10
Neurotensin binding to extraneural and neural receptors: comparison with biological activity and structure--activity relationships. Mol Pharmacol (1980) 1.10
Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation. N Engl J Med (1983) 1.10
High upper critical fields and evidence of weak-link behavior in superconducting LaFeAsO1-xFx thin films. Phys Rev Lett (2010) 1.09
Abdominal surgery-induced delayed gastric emptying in rats: role of CRF and sensory neurons. Am J Physiol (1992) 1.09
Anatomic and phylogenetic distribution of somatostatin. Metabolism (1976) 1.08
Effects of synthetic ovine corticotropin-releasing factor, glucocorticoids, catecholamines, neurohypophysial peptides, and other substances on cultured corticotropic cells. Endocrinology (1983) 1.08